₹ 641.95
-1.85 (-0.29%)Open
644.95High
651.95Low
635.45Prev Close
643.8P/E
52.74Median P/E
30.39P/B
6.39Median P/B
3.78Market Cap
33.99BPEG
1.32Div.Yield
3.37Bid
-Ask
641.50Large Cap
33.99B Mkt. Cap.Volatility
-Beta
0.58Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 646.73 | 646.45 |
10 | 634.15 | 634.17 |
20 | 620.75 | 620.89 |
50 | 626.18 | 626.46 |
100 | 628.84 | 629.09 |
300 | 592.77 | 593.00 |
BSE
539871NSE
THYROCAREISIN
INE594H01019Thyrocare Technologies Limited is an India-based healthcare services provider in diagnostic area. The Company has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that is focused on early detection and management of health disorders and diseases. The Company's segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceutical, selling of consumables for reporting. The Others segment include the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. The Company has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India.
Rahul Guha
Executive Chairman of the Board, Chief Executive Officer, Managing Director, Executive Director, President - OperationsAlok Jagnani
Chief Financial OfficerKallathikumar K
Chief Operating OfficerRamjee Dorai
Chief Compliance Officer, Company SecretaryAditya Shinde
Vice President - FinanceCaesar Sengupta
Vice President - OperationsS. Krishnakumar
General Manager - LabRetheesh Pillai
General ManagerNitin Chugh
Chief Commercial OfficerPreet Kaur
Head - Clinical Operations and Quality